Status:
COMPLETED
Reminder Focused Positive Psychiatry in Adolescents With ADHD and PTSD
Lead Sponsor:
University of California, Los Angeles
Collaborating Sponsors:
Kern Medical
American Academy of Child Adolescent Psychiatry.
Conditions:
Posttraumatic Stress Disorder
Attention Deficit Hyperactivity Disorder
Eligibility:
All Genders
9-18 years
Phase:
NA
Brief Summary
This feasibility study investigates the impact of reminder-focused-positive-psychiatry (RFPP) on attention-deficit-hyperactive-disorder (ADHD) and posttraumatic-stress-disorder (PTSD) symptoms, vascul...
Detailed Description
PTSD and ADHD are major public health problems. Many individuals with comorbid ADHD and PTSD continue to suffer despite treatment with FDA approved medications including antidepressants (sertraline an...
Eligibility Criteria
Inclusion
- English speaking Boy/Girl Age 9 - 18 years old
- Able to read/write in English
- Documented ADHD and PTSD, and parents provided informed consent
Exclusion
- Psychotic or Mood Disorders or Self-injurious behavior
- Cognitive disorder or other neurodevelopmental disorders
- Diagnosis of substance use disorder
Key Trial Info
Start Date :
January 10 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 29 2019
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT04336072
Start Date
January 10 2017
End Date
June 29 2019
Last Update
April 8 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCLA Kern
Los Angeles, California, United States, 93306